NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 206 filers reported holding NEVRO CORP in Q1 2021. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $971,936 | -10.8% | 50,569 | +18.0% | 0.03% | +3.7% |
Q2 2023 | $1,089,628 | -17.7% | 42,865 | +17.1% | 0.03% | -25.0% |
Q1 2023 | $1,323,560 | +4.1% | 36,613 | +14.1% | 0.04% | 0.0% |
Q4 2022 | $1,271,239 | -12.4% | 32,102 | +3.0% | 0.04% | -25.0% |
Q3 2022 | $1,452,000 | +5.2% | 31,166 | -1.0% | 0.05% | +20.0% |
Q2 2022 | $1,380,000 | -29.0% | 31,495 | +17.1% | 0.04% | +2.6% |
Q1 2022 | $1,945,000 | -12.8% | 26,894 | -2.3% | 0.04% | -9.3% |
Q4 2021 | $2,231,000 | -20.7% | 27,525 | +13.9% | 0.04% | -40.3% |
Q3 2021 | $2,812,000 | -7.0% | 24,162 | +32.5% | 0.07% | -25.0% |
Q2 2021 | $3,023,000 | +32.0% | 18,231 | +11.1% | 0.10% | +11.6% |
Q1 2021 | $2,290,000 | +45.7% | 16,414 | +80.7% | 0.09% | +17.8% |
Q4 2020 | $1,572,000 | +172.9% | 9,082 | +119.7% | 0.07% | +121.2% |
Q3 2020 | $576,000 | +93.3% | 4,133 | +65.9% | 0.03% | -32.7% |
Q2 2020 | $298,000 | +183.8% | 2,491 | +137.2% | 0.05% | -14.0% |
Q1 2020 | $105,000 | +26.5% | 1,050 | +48.7% | 0.06% | +235.3% |
Q4 2019 | $83,000 | – | 706 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BRAIDWELL LP | 1,776,368 | $34,141,793 | 1.08% |
ARMISTICE CAPITAL, LLC | 3,456,000 | $66,424,320 | 1.02% |
Palo Alto Investors LP | 386,832 | $7,434,911 | 0.70% |
Rock Springs Capital Management LP | 1,211,600 | $23,286,952 | 0.62% |
ArrowMark Colorado Holdings LLC | 2,468,110 | $47,437,074 | 0.58% |
TD Capital Management LLC | 84,648 | $1,626,935 | 0.20% |
Venator Management LLC | 25,000 | $480,500 | 0.18% |
DAFNA Capital Management LLC | 28,000 | $538,160 | 0.17% |
FRED ALGER MANAGEMENT, LLC | 1,053,812 | $20,254,266 | 0.12% |
Counterpoint Mutual Funds LLC | 6,844 | $131,542 | 0.11% |